Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value Frameworks

Value in Health

Volumn 20, Issue 2, 2017, Pages 193-199

  Cohen, Joshua T ^a   Anderson, Jordan E ^a   Neumann, Peter J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

cost effectiveness analysis; healthcare costs; oncology treatments; value frameworks

Indexed keywords

ALGORITHM; AMERICAN SOCIETY OF CLINICAL ONCOLOGIST FRAMEWORK; ARTICLE; CANCER MORTALITY; CASE STUDY; COMPARATIVE EFFECTIVENESS; CONCEPTUAL FRAMEWORK; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUGABACUS FRAMEWORK; FACE VALIDITY; HUMAN; INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW FRAMEWORK; LOGIC; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SHARED DECISION MAKING; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; HEALTH SERVICES RESEARCH; ONCOLOGY; ORGANIZATION; PURCHASING;

COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; DECISION SUPPORT TECHNIQUES; LOGIC; MEDICAL ONCOLOGY; ORGANIZATIONAL CASE STUDIES; VALUE-BASED PURCHASING;

EID: 85013633699     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2016.11.012     Document Type: Article

References (7)

1. [1] Memorial Sloan Kettering Cancer Center. DrugAbacus—evidence driven drug pricing project. Available from: http://www.drugabacus.org/. [Accessed June 20, 2016].
2. [2] The ASCO Post. ASCO value framework update: a statement by Julie M. Vose, MD, MBA, FASCO. Available from: http://www.ascopost.com/News/41599. [Accessed September 16, 2016].
3. [3] Schnipper, L.E., Davidson, N.E., Wollins, D.S., et al. Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received. J Clin Oncol 34 (2016), 2925–2934.
4. [4] Institute for Clinical and Economic Review. ICER value assessment framework: 1.0 to 2.0. Available from: http://icer-review.org/wp-content/uploads/2016/02/Value-Assessment-Framework-slides-for-July-29-webinar-FINAL.pdf. [Accessed August 1, 2016].
5. [5] Institute for Clinical and Economic Review. ICER response to National Pharmaceutical Council comments on ICER value assessment framework. Available from: http://icer-review.org/wp-content/uploads/2014/01/National-Pharmaceutical-Council-comments-on-ICER-Value-Framework-Assessment-with-ICER-responses-Final1.pdf. [Accessed August 10, 2016].
6. [6] Medscape Medical News. Top 100 selling drugs of 2013. 2014. Available from: http://www.medscape.com/viewarticle/820011. [Accessed April 19, 2016].
7. [7] Neumann, P.J., Cohen, J.T., Measuring the value of prescription drugs. N Engl J Med 373 (2015), 2595–2597.